Cargando…

Correction: Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes

Detalles Bibliográficos
Autores principales:	He, Zhen-Yu, Wu, San-Gang, Zhou, Juan, Li, Fang-Yan, Lin, Qin, Lin, Huan-Xin, Sun, Jia-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689441/ https://www.ncbi.nlm.nih.gov/pubmed/26698859 http://dx.doi.org/10.1371/journal.pone.0145972

Ejemplares similares

Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes
por: He, Zhen-Yu, et al.
Publicado: (2015)

Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients
por: Kheradmand, Ali Arab, et al.
Publicado: (2010)

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
por: Wu, San-Gang, et al.
Publicado: (2014)

Number of Negative Lymph Nodes Can Predict Survival after Postmastectomy Radiotherapy According to Different Breast Cancer Subtypes
por: Wu, San-Gang, et al.
Publicado: (2015)

Impact of Postmastectomy Radiotherapy on Locoregional Control and Disease-Free Survival in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy
por: Zhang, Yanyu, et al.
Publicado: (2021)

Real-world impact of postmastectomy radiotherapy in T1–2 breast cancer with one to three positive lymph nodes
por: Li, Feng-Yan, et al.
Publicado: (2020)

Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients
por: Wang, Jiangfeng, et al.
Publicado: (2020)

Predictive Value of Molecular Subtyping for Locoregional Recurrence in Early-Stage Breast Cancer with N1 without Postmastectomy Radiotherapy
por: Wen, Ge, et al.
Publicado: (2016)

Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy
por: Wu, San-Gang, et al.
Publicado: (2013)

Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer()
por: Van der Vorst, Aline, et al.
Publicado: (2022)

Local and regional recurrence following mastectomy in breast cancer patients with 1–3 positive nodes: implications for postmastectomy radiotherapy volume
por: Park, Shin-Hyung, et al.
Publicado: (2018)

Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
por: Chang, Jee Suk, et al.
Publicado: (2015)

Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy
por: Wang, Xin, et al.
Publicado: (2018)

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
por: Chen, Xingxing, et al.
Publicado: (2018)

Is Postmastectomy Radiotherapy Really Needed in Breast Cancer Patients with Many Positive Axillary Lymph Nodes?
por: Marinko, Tanja, et al.
Publicado: (2018)

Effects of postmastectomy radiotherapy on prognosis in different tumor stages of breast cancer patients with positive axillary lymph nodes
por: Jia, Miao-Miao, et al.
Publicado: (2014)

Clinical decision making in postmastectomy radiotherapy in node negative breast cancer
por: Barrientos, Rodrigo, et al.
Publicado: (2018)

Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1–3 positive lymph nodes: a retrospective study
por: Chitapanarux, Imjai, et al.
Publicado: (2014)

Impact of AJCC prognostic staging on prognosis and postmastectomy radiotherapy decision-making in hormone receptor-positive and HER2-positive breast cancer
por: Li, Guan-Qiao, et al.
Publicado: (2022)

Lymph node ratio may predict the benefit of postoperative radiotherapy in node-positive cervical cancer
por: Zhou, Juan, et al.
Publicado: (2016)

Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy
por: Li, Jin-luan, et al.
Publicado: (2017)

Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence‐free survival
por: Daskalakis, Kosmas, et al.
Publicado: (2022)

Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer
por: Wu, San-Gang, et al.
Publicado: (2015)

Automated treatment planning of postmastectomy radiotherapy
por: Kisling, Kelly, et al.
Publicado: (2019)

Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
por: Lai, Shih-Fan, et al.
Publicado: (2019)

Role of postmastectomy radiation therapy in breast cancer patients with T1–2 and 1–3 positive lymph nodes
por: Cihan, Yasemin Benderli, et al.
Publicado: (2016)

Dosimetric Comparison of Postmastectomy Radiotherapy Plans for Synchronous Bilateral Breast Cancer, Including Regional Lymph Node Irradiation
por: Wu, Xiuxiu, et al.
Publicado: (2023)

Impact of the number of resected lymph nodes on survival after preoperative radiotherapy for esophageal cancer
por: Wu, San-Gang, et al.
Publicado: (2016)

Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer
por: Xia, Lin-Yu, et al.
Publicado: (2022)

Long-term survival in node-positive breast cancer treated by locoregional therapy alone.
por: Joensuu, H., et al.
Publicado: (1998)

A Hybrid Conformal Planning Technique with Solitary Dynamic Portal for Postmastectomy Radiotherapy with Regional Nodes
por: Rafic, K. Mohamathu, et al.
Publicado: (2017)

Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes
por: Yin, Hang, et al.
Publicado: (2017)

Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes
por: Kim, Sang-Won, et al.
Publicado: (2017)

The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype
por: Wei, Jinli, et al.
Publicado: (2020)

Chronic hyperglycemia is an adverse prognostic factor for locoregional recurrence‐free survival in small cell lung cancer patients treated with radical radiotherapy
por: Kong, Moonkyoo, et al.
Publicado: (2022)

A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1–2 Breast Cancer With 1–3 Positive Axillary Lymph Nodes
por: Hou, Niuniu, et al.
Publicado: (2021)

Postmastectomy radiation therapy can improve survival for breast cancer patients with 1–3 positive axillary lymph nodes: a retrospective cohort study using the SEER database
por: Yang, Jian, et al.
Publicado: (2021)

Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma
por: Hu, Jiyi, et al.
Publicado: (2020)

A prospective feasibility study of a 1-mm bolus for postmastectomy radiotherapy
por: Kawamoto, Terufumi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h41pqhtgb0ulahpjlv7gn54v7j